ESRP1 and small cell lung carcinoma: Consistent with the role of ESRP1 in EMT and stemness, ESRP1 overexpression increased the sensitivity of small-cell lung cancer cells to chemotherapy by regulating alternative splicing of CARM1, thereby inhibiting TGF-β/Smad signaling [46].